All posts by Genetic Signatures

Genetic Signatures exhibiting at AMP 2017 Salt Lake City, Utah 16-18 November 2017

By | Latest News | No Comments

Genetic Signatures are exhibiting at the Association for Molecular Pathology (AMP) Annual meeting 2017 in Salt Lake City, Utah 16-18 November.

The AMP Annual Meeting is:

  • The premier educational event for molecular pathology professionals from around the world.
  • The only educational event developed and presented by internationally renowned molecular diagnostic professionals.
  •  The dedicated forum for first-time presentation of rigorously peer-reviewed abstracts, destined for publication in The Journal of Molecular Diagnostics.
  • The source for practical applications of clinically proven molecular diagnostics – ultimately improving patient care.

You are invited to visit Genetic Signatures at Booth no. 1005 at AMP 2017 for more information.

Click here to visit the AMP 2017


About the Association for Molecular Pathology:

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s 2,300+ members practice in the various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions, and oncology. Our members include pathologists, doctoral scientist laboratory directors, basic and translational scientists, technologists, and trainees from academic and community medical centers, government, and industry. Through the efforts of its Board of Directors, Committees, Working Groups, and Members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.

 

 

Hear about Genetic Signatures EasyScreen™ Kits at the upcoming 2017 NRL Workshop on Molecular Diagnostics

By | Latest News | No Comments

Genetic Signatures EasyScreen™ Pathogen Detection Kits will be featured in an oral presentation at the upcoming National Reference Laboratory (NRL) Workshop on Molecular Diagnostics on the 16-17th October 2017 Hobart, Australia.

The presentation entitled “A 3baseTM Real-Time Multiplex-PCR for the detection of Extended- Spectrum β -Lactamases (ESBL) and Carbapenemase- Producing Organisms (CPO) will be given by our talented Product Development Scientist Mr. Dilshan Abeysekera.

The NRL Molecular Workshop is a forum for scientists, regulators, test kit manufacturers and clinicians to unite and discuss current issues and new technologies occurring in the world of molecular pathology for infectious diseases. The aim of this workshop is to focus specifically on molecular techniques involved in detecting infectious pathogens.

 Visit the conference website for more information: NRL Molecular Diagnostic Workshop


About ESBL and CPO: ESBLs are enzymes that mediate resistance to extended-spectrum (third generation) cephalosporins and monobactams but do not affect cephamycins or carbapenems. The presence of an ESBL-producing organism in a clinical infection can result in treatment failure if one of the above classes of drugs is used. ESBLs can be difficult to detect because they have different levels of activity against various cephalosporins. Thus, the choice of which antimicrobial agents to test is critical. 1

 CPO or CRE, which stands for carbapenem-resistant Enterobacteriaceae or organisms, are a family of germs that are difficult to treat because they have high levels of resistance to antibiotics. Klebsiella species and Escherichia coli (E. coli) are examples of Enterobacteriaceae, a normal part of the human gut bacteria, that can become carbapenem-resistant. Types of CRE are sometimes known as KPC (Klebsiella pneumoniae carbapenemase) and NDM (New Delhi Metallo-beta-lactamase). KPC and NDM are enzymes that break down carbapenems and make them ineffective. Both of these enzymes, as well as the enzyme VIM (Verona Integron-Mediated Metallo-β-lactamase) have also been reported in Pseudomonas.

Healthy people usually do not get CRE infections – they usually happen to patients in hospitals, nursing homes, and other healthcare settings. Patients whose care requires devices like ventilators (breathing machines), urinary (bladder) catheters, or intravenous (vein) catheters, and patients who are taking long courses of certain antibiotics are most at risk for CRE infections.

Some CRE bacteria have become resistant to most available antibiotics. Infections with these germs are very difficult to treat, and can be deadly—one report cites they can contribute to death in up to 50% of patients who become infected.2

About the EasyScreen™ Antibiotic Resistance Detection Kit: The EasyScreen™ Antibiotic Resistance Detection Kit detects the most common resistant markers. ESBL and CPO targets that are detected are β –Lactamases TEM, SHV, CTX-M, CMY, DHA,OXA-48 like , OXA- 23 like, OXA-51 like, GES, MCR-1,IMI,SME, , New Delhi Metallo- β –Lactamases (NDM), Klebsiella pneumoniae carbapenemase (KPC), Metallo- β –Lactamases VIM, Metallo- β –Lactamases IMP.

References:
1. https://www.cdc.gov/hai/settings/lab/lab_esbl.html
2. https://www.cdc.gov/hai/organisms/cre/index.html

Genetic Signatures to exhibit and present at the 10th European Meeting on Molecular Diagnostics (EMMD), Noordwijk, Netherlands

By | Latest News | No Comments

Genetic Signatures are proud to announce the exhibition and presentation at the 10th European Meeting on Molecular Diagnostics (EMMD) on the 11-13th October 2017 Noordwijk, Netherlands.

This biannual event with multiple keynote speakers provides a unique opportunity to showcase applications in novel molecular technologies as well as highlight the key aspects required in Molecular Diagnostics.

We are pleased to announce that Genetic Signatures Director, US Technical Operations Dr. Richard Smith will be presenting.

Session 9: New Diagnostics Technologies

Friday October 13th, 2017 at 15:25 – 15:40 (CEST)

Rapid, Sensitive and Automated Detection of Pathogenic Targets with the Multiplexed EasyScreen™ 3base™ Assays

Please visit Genetic Signatures at Booth 14 to learn more about our novel 3baseTM technology and applications with our EasyScreenTM Detection Kits.

Visit the conference website for more information: EMMD


 

About EMMD: This is the 10th European Meeting on Molecular Diagnostics (EMMD), devoted to all aspects of molecular diagnostics in human disease and pathology. The EMMD is organised every two years in the Netherlands. These meetings are a continuation of the former Benelux- and European meetings on PCR diagnostics. However, the scope of the meeting has expanded to include other amplification techniques, general probe technology and applications in a wide diversity of laboratory disciplines such as Clinical Microbiology, Virology, Pathology, Clinical Chemistry, Clinical Genetics, Pharmacogenetics, Hematology, and Oncology.

The emphasis of this multi-disciplinary meeting is on novel molecular technologies and innovative applications in the diagnosis, monitoring, and screening of human diseases. Presentations will consist of invited-lectures by internationally renowned experts in combination with selected abstract presentations. Poster sessions and industrial exhibits will be an integrated part of the meeting.

 

Genetic Signatures to present at ASM Tri-State Scientific Meeting & Parasitology Masterclass 22-25 September, Darwin, Australia.

By | ASX Announcements, Latest News | No Comments

Genetic Signatures have been invited to present at the 2017 ASM Tri-State Scientific Meeting & Parasitology Masterclass 22-25 September, Darwin, Australia.

Genetic Signatures Chief Scientific Officer (CSO) Dr. Doug Millar will be presenting the results on the development of a 3baseTM Flavivirus and Alphavirus EasyScreenTM Detection assay. The test allows for the detection of 17 of the most common flavivirus and alphavirus infections in the world, including dengue, West Nile virus, Zika, yellow fever virus, and chikungunya.

We invite you to hear Dr. Millar’s presentation at Tri-State Scientific Meeting & Parasitology Masterclass: Monday 25th September 2017 at 11:30 am (EST)

Click here to visit the ASM website


About ASM Tri-State Scientific Meeting & Parasitology Masterclass 2017: Tri-State meetings have been initiated and supported by ASM branches in SA, WA and NT for over 25 years. The aim of this meeting is to bring delegates together in an intimate and unique environment. Expect a varied and engaging scientific program presented by some of Australia’s top microbiologists.

The Parasitology Masterclass began with its inaugural meeting in Tasmania in 2009, this is the 6th Parasitology Masterclass, it aims to again provide an excellent blend of wet workshops, classroom teaching, and formal presentations.

Genetic Signatures to Exhibit and Present at the annual Australian Society of Microbiology (ASM) meeting, 2-5 July, Hobart, Tasmania

By | Latest News | No Comments

Genetic Signatures are proud to exhibit at the Australian Society for Microbiology Annual Scientific Meeting (ASM) 2017 in Hobart, Tasmania on 2-5 July 2017.

Genetic Signatures has also been selected to present 4 oral papers at ASM 2017 Tasmania, in the following sessions:

  • Monday 3rd July, 2017 10:30-12:00pm EST
    Session: Laboratory Processes and Automation
    “Clinical evaluation of the 3base™ EasyScreenTM Enteric Viral Detection Kit EV002”
  • Monday 3rd July, 2017 15.30-17:00pm EST
    Session: Virus-host interactions
    “A novel 3base™ assay for the rapid detection of flavivirus/alphavirus in clinical samples
  • Tuesday 4th July, 2017 10:30-12:00pm EST
    Session: New Clinical Microbiology Diagnostics
    “A 3base™ Real-Time Multiplex-PCR method for the detection of Extended-Spectrum β-Lactamases (ESBL) and Carbapenemase-Producing Organisms (CPO)”
  • Tuesday 4rd July, 2017 15:30-17:00pm EST
    Session: STIs and Diagnostics
    “Rapid, Sensitive and Automated Detection of 12 Bacterial and Viral Causes of Sexually Transmitted Infections using the 3base™ EasyScreenTM Sexually Transmitted/Genital Detection Kit”

You are invited to visit Genetic Signatures at Booth no. 17 and to attend the oral presentations at ASM 2017 Tasmania.

Click here to visit the ASM 2017 Tasmania website

Planetary Health ASM 2017 Hobart


About ASM 2017 Tasmania: The Australian Society for Microbiology Annual Scientific Meeting (ASM) was formed in 1959 as a learned society devoted to furthering the science of microbiology. The ASM became an incorporated professional society in 1976.

With the theme of Planetary Health, the scientific program emphasizes the interdependent nature of life on Earth and how this relates to the health of mankind. An exciting new discipline, Planetary Health encompasses broad microbial systems that impact disease and epidemiology, climate change, food production and many broad natural systems. The annual meeting represents an opportunity to showcase products and technology to over 500 delegates from both diagnostic and research backgrounds.